Serving as a JTC editor offers opportunities to shape the direction of thyroid cancer research and collaborate with leading experts.

Editors gain early insight into emerging therapies, diagnostics, and clinical practice changes.

• Early access to emerging research
• Opportunities to lead special issues
• Editorial experience in peer review management
• Recognition on the journal website
• Certificate of service on request
• Encourage consistent decision letters and clear revision guidance.
• Ensure reviewer expertise matches thyroid cancer subtopics.
• Confirm ethics approvals and patient consent documentation.
• Monitor turnaround times and communicate delays promptly.
• Promote data transparency and reproducibility statements.
• Document conflicts of interest and recuse when needed.
• Coordinate with guest editors to align on scope fit.
• Verify clinical trial registration and reporting quality.
• Ensure statistical review for complex molecular studies.
• Request data access statements for sensitive clinical datasets.
• Encourage adherence to CONSORT, STROBE, PRISMA, or CARE.
• Check that imaging and pathology reporting are adequate.
• Ensure conclusions align with data and avoid overstatement.
• Promote clear reporting of surgical and systemic treatment details.
• Encourage reporting of staging criteria and risk stratification.
• Verify that surgical and adjuvant therapy details are complete.
• Request clarification on imaging criteria and response assessments.

JTC is committed to rigorous, transparent publishing in thyroid cancer research and care. We emphasize reproducible clinical methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in endocrine oncology, surgical outcomes, and translational thyroid research.